Price T Rowe Associates Inc Eli Lilly & CO Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,133,284 shares of LLY stock, worth $13.9 Billion. This represents 1.95% of its overall portfolio holdings.

Number of Shares

19,133,284

Previous 20,863,968 8.3%

Holding current value

$13.9 Billion

Previous $16.1 Billion 1.89%

% of portfolio

1.95%

Previous 1.86%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$725.72 - $929.72 $1.26 Billion - $1.61 Billion	-1,730,684 Reduced 8.3%	19,133,284 $15.8 Billion
Q4 2024 Feb 14, 2025	SELL	$727.2 - $932.06 $48.2 Million - $61.8 Million	-66,319 Reduced 0.32%	20,863,968 $16.1 Billion
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $215 Million - $267 Million	278,551 Added 1.35%	20,930,287 $18.5 Billion
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $28 Million - $35.2 Million	38,675 Added 0.19%	20,651,736 $18.7 Billion
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $719 Million - $961 Million	-1,213,514 Reduced 5.56%	20,613,061 $16 Billion
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $215 Million - $253 Million	-409,417 Reduced 1.84%	21,826,575 $12.7 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $837 Million - $1.15 Billion	-1,924,967 Reduced 7.97%	22,235,992 $11.9 Billion
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $504 Million - $674 Million	1,438,225 Added 6.33%	24,160,959 $11.3 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $16.7 Million - $19.6 Million	53,744 Added 0.24%	22,722,734 $7.8 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $698 Million - $813 Million	-2,170,332 Reduced 8.74%	22,668,990 $8.29 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.31 Billion - $1.49 Billion	4,412,664 Added 21.6%	24,839,322 $8.05 Billion
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $139 Million - $163 Million	-498,109 Reduced 2.38%	20,426,658 $6.62 Billion
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1 Billion - $1.24 Billion	-4,259,691 Reduced 16.91%	20,924,767 $5.99 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1.14 Billion - $1.42 Billion	-5,071,623 Reduced 16.76%	25,184,458 $6.96 Billion
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $779 Million - $959 Million	3,516,865 Added 13.15%	30,256,081 $6.99 Billion
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $105 Million - $136 Million	584,215 Added 2.23%	26,739,216 $6.14 Billion
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $2.31 Billion - $2.99 Billion	14,060,388 Added 116.25%	26,155,001 $4.89 Billion
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $1.58 Billion - $2.09 Billion	12,094,613 New	12,094,613 $2.04 Billion

Others Institutions Holding LLY

# of Institutions

4,383

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $689B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Eli Lilly & CO Transaction History